Wutah bathi EPS kuartalan zentaris.com (AEZS)

Simbol lan logo merek zentaris.com (AEZS)

Aeterna Zentaris (AEZS) is expanding its network of partner clinics through licensing deals in the mature diagnostics market. The quarterly EPS growth rate on this chart clearly demonstrates the financial dynamics, where the current metric equals 0.00. Revenues are based on Macrilen test sales and royalties. Stable demand for specialized studies makes this defensive business resilient to economic fluctuations.

AEZS: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan Aeterna Zentaris Inc. 04.07.2022 - 17.08.2024

zentaris.com (AEZS) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Aeterna Zentaris
Barang unggulan Aeterna Zentaris

Investors assess capital risks through net income dynamics, where any deviation from the trend signals potential volatility. For Aeterna Zentaris (AEZS), which focuses on the commercialization of tests and endocrinology developments, the quarterly EPS growth rate measures the speed of change in earnings per share, allowing for the identification of business value growth phases and the probability of generating alpha during an upward trend.

Karo sapa Aeterna Zentaris saingan

VRTX: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Alnylam Inc. (ALNY)|INSM (Insmed) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan UTHR (United Therapeutics Corporation)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BMRN (BioMarin)|BBIO (BridgeBio Pharma) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan BGM (BGM Group Ltd)|COGT (Cogent Bio) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Xeris Biopharma - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KROS (Keros Therapeutics)|ARCT: Wutah bathi EPS kuartalan|Eton Pharmaceuticals Inc (ETON) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Kamada Corp|FULC: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Abeona Therapeutics, Inc. (ABEO)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Mereo BioPharma Group plc MREO|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Protalix BioTherapeutics PLX|Wutah bathi EPS kuartalan Pliant Therapeutics PLRX|appliedtherapeutics.com - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan RNTX (Rein Therapeutics, Inc.)|GELS: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan SRXH (SRx Health Solutions)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan PLRZ (Polyrizon Ltd)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Reneo Pharmaceuticals, Inc. (RPHM) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|COSCIENS Bio - Wutah bathi EPS kuartalan